Using proton magnetic resonance imaging and spectroscopy to understand brain "activation"

Brain and Language

Volumn 102, Issue 2, 2007, Pages 153-164

  Baslow, Morris H ^a   Guilfoyle, David N ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Cognition; Hyperemia; Metabotropic glutamate receptor 3; N Acetylaspartate: N Acetylaspartylglutamate; NAAG peptidase

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUCOSE; N ACETYLASPARTYLGLUTAMIC ACID; NEUROPEPTIDE; OXYGEN;

ARTICLE; ASTROCYTE; BIOENERGY; BIOSYNTHESIS; BLOOD OXYGENATION; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN METABOLISM; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM FUNCTION; COGNITION; DEPOLARIZATION; ENERGY METABOLISM; ENZYME INHIBITION; FEEDBACK SYSTEM; GLUCOSE BLOOD LEVEL; HUMAN; HYPEREMIA; LANGUAGE; NERVE STIMULATION; NEUROMODULATION; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN BLOOD LEVEL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; REPOLARIZATION; SIGNAL TRANSDUCTION; SPIKE; TASK PERFORMANCE;

ANIMALS; BRAIN; BRAIN MAPPING; DIPEPTIDES; HUMANS; HYPEREMIA; MAGNETIC RESONANCE SPECTROSCOPY; NEURONS; PROTONS; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 34250790114     PISSN: 0093934X     EISSN: 10902155     Source Type: Journal    
DOI: 10.1016/j.bandl.2006.06.119     Document Type: Article

References (54)

1. Bartels A., and Zeki S. The chronoarchitecture of the human brain-natural viewing conditions reveal a time-based anatomy of the brain. Neuroimage 22 (2004) 419-433
2. Baslow M.H. A review of phylogenetic and metabolic relationships between the acylamino acids, N-acetyl-laspartic acid and N-acetyl-l-histidine in the vertebrate nervous system. Journal of Neurochemistry 68 4 (1997) 1335-1344
3. Baslow M.H. Functions of N-acetyl-laspartate and N-acetyl-l aspartylglutamate in the vertebrate brain. Role in glial cell-specific signaling. Journal of Neurochemistry 75 (2000) 453-459
4. Baslow M.H. Evidence supporting a role for N-acetyl-laspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review. Neurochemistry International 40 4 (2002) 295-300
5. Baslow M.H. N-acetylaspartate in the vertebrate brain: Metabolism and function. Neurochemical Research 28 6 (2003) 941-953
6. Baslow M.H. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: A mechanistic explanation. Journal of Molecular Neuroscience 21 (2003) 185-189
7. Baslow M.H. NAAG peptidase as a therapeutic target: Potential for regulating the link between glucose metabolism and cognition. Drug News and Perspectives 19 3 (2006) 145-150
8. Baslow M.H., and Guilfoyle D.N. N-Acetylaspartate A unique neuronal molecule in the central nervous system. Advances in Experimental Medicine and Biology 576 (2006) 95-112
9. Baslow M.H., Dyakin V.V., Nowak K.L., Hungund B.L., and Guilfoyle D.N. 2-PMPA, a NAAG peptidase inhibitor, attenuates the BOLD signal in brain of anesthetized mice: Evidence of a link between NAAG release and hyperemia. Journal of Molecular Neuroscience 26 3 (2005) 1-16
10. Baslow M.H., and Resnik T.R. Canavan disease: Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms. Journal of Molecular Neuroscience 9 2 (1997) 109-126
11. Baslow M.H., Suckow R.F., Gaynor K., Bhakoo K.K., Marks N., Saito M., et al. Brain damage results in downregulation of N-acetylaspartate as a neuronal osmolyte. Neuromolecular Medicine 3 2 (2003) 95-103
12. Battistuta J., Bjartmar C., and Trapp B.D. Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate: An HPLC analysis of different rat CNS regions. Neurochemical Research 26 (2001) 695-702
13. Boltshauser E., Schmitt B., Wevers R.A., Engelke U., Burlina A.B., and Burlina A.P. Follow-up of a child with hypoacetylaspartia. Neuropediatrics 35 4 (2004) 255-258
14. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Annals of the New York Academy of Sciences 508 (1987) 333-348
15. 13C) MRS and fMRI. Magnetic Resonance in Medicine 45 (2001) 349-355
16. Clifford C.W., and Ibbotson M.R. Response variability and information transfer in directional neurons of the mammalian horizontal optokinetic system. Visual Neuroscience 17 (2000) 207-215
17. Coyle J.T. The nagging question of the function of N-acetylaspartylglutamate. Neurobiology of Disease 4 (1997) 231-238
18. de Graaf R.A. In Vivo NMR spectroscopy principles ad techniques (1998), J. Wiley and Sons Ltd, Chichester, England
19. Drake C.T., and Ladecola C. Role of neuronal signaling in controlling cerebral blood flow. Brain and Language 102 (2006) 141-152
20. Egan M.F., Straub R.E., Goldberg T.E., Yakub I., Callicott J.H., Hariri A.R., et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 101 34 (2004) 12604-12609
21. Fallgatter A.J., Ehlis A.Ch., Wagener A., Michel T., and Herrmann M.J. Near-infrared spectroscopy in psychiatry [German]. Nervenartz 75 9 (2004) 911-916
22. Feng C.-M., Narayana S., Lancaster J.L., Jerabek P.A., Arnow T.L., Zhu F., et al. CBF changes during brain activation: fMRI vs PET. Neuroimage 22 (2004) 443-446
23. Frahm J., Merboldt K.D., and Hanicke W. Localized proton spectroscopy using stimulated echoes. Journal of Magnetic Resonance 72 (1987) 502-508
24. Gangstead S.L., and Song A.W. On the timing characteristics of the apparent diffusion coefficient contrast in fMRI. Magnetic Resonance in Medicine 48 (2002) 385-388
25. Goldman M.S., Maldonado P., and Abbott L.F. Redundancy reduction and sustained firing with stochastic depressing synapses. Journal of Neuroscience 22 2 (2002) 584-591
26. Guilfoyle D.N., and Hrabe J. REST-PEEP: reduced scan time phase encoded echo planar imaging. NMR in Biomedicine 16 (2003) 269-275
27. 1H MR spectroscopy by short echo time STEAM sequence. Magnetic Resonance Materials in Physics Biology and Medicine 10 (2000) 6-17
28. Huettel S.A., McKeown M.J., Song A.W., Hart S., Spencer D.D., Allison T., et al. Linking hemodynamics and electrophysiological measures of brain activity: Evidence from functional MRI and intracranial field potentials. Cerebral Cortex 14 (2004) 165-173
29. Hyder F., Kida I., Behar K.L., Kennan R.F., Maciejewski P.K., and Rothman D.L. Quantitative functional imaging of the brain: towards mapping neuronal activity by BOLD fMRI. NMR in Biomedicine 14 (2001) 413-431
30. Kuperberg G.R., Holcomb P.J., Sitnikova T., Greve D., Dale A.M., and Caplan D. Distinct patterns of neural modulation during processing of conceptual and syntactic anomalies. Journal of Cognitive Neuroscience 15 2 (2003) 272-293
31. Lei H., Zhang Y., Zhu X.H., and Chen W. Changes in proton T2 relaxation times of cerebral water and metabolites during forebrain ischemia in rat at 9.4 T. Magnetic Resonance in Medicine 49 6 (2003) 979-984
32. Lennie P. The cost of cortical computation. Current Biology 13 (2003) 493-497
33. Logothetis N.K. The underpinnings of the BOLD functional magnetic resonance imaging signal. Journal of Neuroscience 23 (2003) 3963-3971
34. Ogawa S., Menon R.S., Tank D.W., Kim S.G., Merkle H., Ellerman J.M., et al. Functional brain mapping by blood oxygenation level dependent contrast magnetic resonance imaging. Biophysical Journal 64 (1993) 803-812
35. Patel A.B., de Graaf R.A., Mason G.F., Kanamatsu T., Rothman D.L., Shulman R.G., et al. Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation. Journal of Cerebral Blood Flow and Metabolism 24 9 (2004) 972-985
36. 1H nuclear magnetic resonance spectroscopy in vivo. Journal of Cerebral Blood Flow and Metabolism 20 (2000) 736-746
37. Posse S., Dager S., Richards T.L., Yuan C., Ogg R., Artru A.A., et al. In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance proton echo planar spectroscopic imaging (PEPSI). Magnetic Resonance in Medicine 37 (1997) 858-865
38. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30 (1993) 672-679
39. Qutub A.A., and Hunt C.A. Glucose transport to the brain: a systems model. Brain Research. Brain Research Reviews 49 3 (2005) 595-617
40. Raichle M.E., and Gusnard D.A. Appraising the brain's energy budget. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 10237-10239
41. Sartorius L.J., Nagappan G., Lipska B.K., Lu B., Sei Y., Ren-Patterson R., et al. Alternative splicing of human metabotropic glutamate receptor 3. Journal of Neurochemistry 96 (2006) 1139-1148
42. Simard M., and Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 129 (2004) 877-896
43. Smith A.J., Blumenfeld H., Behar K.L., Rothman D.L., Shulman R.G., and Hyder F. Cerebral energetics and spiking frequency: the neurophysiological basis of fMRI. Proceedings of the National Academy of Sciences of the United States of America 99 16 (2002) 10765-10770
44. Somogyi P., and Klausberger T. Defined types of cortical interneurone structure space and spike timing in the hippocampus. The Journal of Physiology (London) 562 1 (2005) 9-26
45. Song A.W., Fichtenholtz H., and Woldorff M. BOLD signal compartmentalization based on apparent diffusion coefficient. Magnetic Resonance Imaging 20 (2002) 521-525
46. Song A.W., Harshbarger T., Li T., Kim K.H., Ugurbil K., Mori S., et al. Functional activation using apparent diffusion coefficient-dependent contrast allows better spatial localization to the neuronal activity: evidence using diffusion tensor imaging and fiber tracking. Neuroimage 20 (2003) 955-961
47. Tomasi D., Chang L., Caparelli E.deC., Telang F., and Ernst T. The human immunodeficiency virus reduces network capacity: Acoustic noise effect. Annals of Neurology 59 (2006) 419-423
48. Urazaev A.K., Grossfeld R.M., and Lieberman E.M. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors. Journal of Neurochemistry 93 (2005) 605-610
49. Vrenken H., Barkhof F., Uitdehaag B.M.J., Castelijns J.A., Polman C.H., and Pouwels P.J.W. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magnetic Resonance in Medicine 53 (2005) 256-266
50. Wellard R.M., Briellmann R.S., Jennings C., and Jackson G.D. Physiologic variability of single-voxel proton MR spectroscopic measurements at 3 T. American Journal of Neuroradiology 26 (2005) 585-590
51. Wroblewska B., Wegorzewska I.N., Bzdega T., Olszewski R.T., and Neale J.H. Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes. Journal of Neurochemistry 96 (2006) 1071-1077
52. Zarahn E. Spatial localization and resolution of BOLD fMRI. Current Opinion in Neurobiology 11 (2001) 209-212
53. 1H MRS study at 4 T. Magnetic Resonance in Medicine 46 (2001) 841-847
54. Zonta M., Angulo M.C., Gobbo S., Rosengarten B., Hossmann K.-A., Pozzan T., et al. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nature Neuroscience 6 1 (2003) 43-50